Navigation Links
MedClean Technologies Inc. Announces New Ticker Symbol
Date:1/26/2009

Common Stock Begins Trading Under Stock Symbol MCLN as of January 26, 2009

BETHEL, Conn.,Jan. 26 /PRNewswire-FirstCall/ -- MedClean Technologies, Inc., a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste, today announced that it has received notification from The NASDAQ Stock Market LLC(R) that NASDAQ has received the necessary documentation to process their request for a name change from Aduromed Industries, Inc. to MedClean Technologies, Inc. The Company will begin trading under the new stock symbol, "MCLN," on the OTC Bulletin Board at the open of business on January 26, 2009.

This action was commenced as part of the Company's rebranding initiative launched January 2, 2009 to capture leadership in the $2 billion market opportunity for regulated medical waste treatment solutions.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

    Contacts:
    MedClean Technologies, Inc.
    Kevin Dunphy
    Chief Financial Officer
    (203) 798-1080
    kdunphy@medcleantechnologies.com

    Investor Contact:
    Cameron Donahue
    Hayden IR
    (651) 653-1854
    cameron@haydenir.com


'/>"/>
SOURCE MedClean Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SeQual Technologies is Awarded the U.S. Army Airworthiness Certification
2. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
3. China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries
4. VirtualHealth Technologies, Inc. Unveils Strategy to Leverage $20 Billion Federal Health IT Proposal
5. Deep Web Technologies Mednar Is Rated the #1 Alternative Health Search Engine
6. Global Med Technologies(R) Inlog Subsidiary Licensed EdgeTrack to 62 French Hospitals in 2008, Including 19 Hospitals in Q4 2008
7. Houstons NuPhysicia LLC has Remote Medical Technologies and Services Featured on CNN Health Report
8. Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
9. InSet Technologies Completes $25 Million Financing
10. HotHead Technologies Working with Schutt Sports to Develop Smart Helmet
11. STEMCELL Technologies Launches Direct Distribution to Singapore
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... expanded distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark ... patients with diabetes. The GlycoMark test provides a clinically proven one- to two-week ...
(Date:4/28/2017)... ... 2017 , ... Children and adolescents who enter the foster ... in the general population. That’s because foster care is designed to protect children ... no fault of their own, youth who have experienced trauma often have difficulty ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain company ... Tina Howe joined the team, the Bill Howe brand was born and they began ... and giving back to the San Diego community in which they worked, lived and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... respiratory hospital, based in Denver, Colorado, announced an agreement to create the Jane ... continuing support of the Jane and Leonard Korman Family Foundation. The collaboration leverages ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... 19, 2017 Companion ... response in pets such as canine, avian and ... various types such as Attenuated Live Vaccines, Conjugate ... Vaccines and Recombinant Vaccines. Attenuated live vaccines are ... bacteria, which have been weakend under laboratory conditions. ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: